Virginia Legislature Gives CDC, Board of Health Power to Mandate Vaccines for School Children
In the 2020 Legislative session, the Virginia Legislature passed H.B.1090, a bill that amended a law requiring children attending public and private schools in the state to receive vaccines (§ 32.1-46. Immunization of patients against certain diseases).1 Virginia Delegate Patrick Hope (D-Arlington) was the lead sponsor of H.B. 1090 introduced on Jan. 8, 2020, which […]
COVID-19 Vaccine Will Likely Be Given Multiple Times, Perhaps Annually
In an interview with the JAMA on June 2, 2020, Anthony Fauci, MD, director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said that while he was “cautiously optimistic” about the effectiveness of the vaccines being developed for COVID-19, he was concerned that any protection the vaccines may provide might only be temporary. […]
Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine
A recent poll conducted by the Associated Press’s NORC Center for Public Affairs Research found that 20 percent of Americans anticipate that a COVID-19 vaccine will be available to the public before the end of 2020, while 61 percent expect it during 2021. Only 17 percent believe it will take longer than that to develop.1 […]
Volunteer Describes His Serious Reaction in Moderna’s mRNA COVID-19 Vaccine Trial
Of the 45 volunteers in biotechnology company Moderna, Inc.’s Phase 1 human clinical trial on its experimental mRNA-1273 vaccine for COVID-19, only the names of the first two participants have been widely publicized—Jennifer Haller of Seattle, Washington and Neal Browning of Bothell, Washington. The clinical trial began on Mar. 16, 2020 at Kaiser Permanente Washington […]
Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in U.S.
Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]
GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant
Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]